Diverse effects of prostaglandin e2on vascular contractility

Heart and Vessels

Volumn 29, Issue 3, 2014, Pages 390-395

  Kida, Taiki ^a   Sawada, Kei ^a   Kobayashi, Koji ^a   Hori, Masatoshi ^a   Ozaki, Hiroshi ^a   Murata, Takahisa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Contraction; EP receptor; Relaxation; Vascular smooth muscle

Indexed keywords

NORADRENALIN; POTASSIUM; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; MESSENGER RNA; PROSTAGLANDIN E RECEPTOR; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; BLOOD VESSEL CONTRACTILITY; BLOOD VESSEL PARAMETERS; BLOOD VESSEL TONE; CONCENTRATION RESPONSE; MALE; MESENTERIC ARTERY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIL ARTERY; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; AGONISTS; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT; TAIL; VASOCONSTRICTION; VASODILATATION;

ANIMALS; AORTA; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER; TAIL; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 84905195032     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-013-0374-6     Document Type: Article

References (26)

1. Daniels EG, Hinman JW, Leach BE, Muirhead EE (1967) Identification of prostaglandin E2 as the principal vasodepressor lipid of rabbit renal medulla. Nature 215:1298-1299
2. Ushikubi F, Segi E, Sugimoto Y, Murata T, Matsuoka T, Kobayashi T, Hizaki H, Tuboi K, Katsuyama M, Ichikawa A, Tanaka T, Yoshida N, Narumiya S (1998) Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395:281-284 (Pubitemid 28447553)
3. Hatazawa R, Tanaka A, Tanigami M, Amagase K, Kato S, Ashida Y, Takeuchi K (2007) Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors. Am J Physiol Gastrointest Liver Physiol 293:G788-G797 (Pubitemid 47605917)
4. Anderson RJ, Berl T, McDonald KM, Schrier RW (1976) Prostaglandins: effects on blood pressure, renal blood flow, sodium and water excretion. Kidney Int 10:205-215
5. Regan JW (2003) EP2 and EP4 prostanoid receptor signaling. Life Sci 74:143-153
6. Hatae N, Sugimoto Y, Ichikawa A (2002) Prostaglandin receptors: advances in the study of EP3 receptor signaling. J Biochem 131:781-784 (Pubitemid 34717580)
7. Sugimoto Y, Narumiya S (2007) Prostaglandin E receptors. J Biol Chem 282:11613-11617 (Pubitemid 47100657)
8. Lawrence RA, Jones RL (1992) Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein. Br J Pharmacol 105:817-824
9. Walch L, Labat C, Gascard JP, de Montpreville V, Brink C, Norel X (1999) Prostanoid receptors involved in the relaxation of human pulmonary vessels. Br J Pharmacol 126:859-866 (Pubitemid 29103701)
10. Davis RJ, Murdoch CE, Ali M, Purbrick S, Ravid R, Baxter GS, Tilford N, Sheldrick RL, Clark KL, Coleman RA (2004) EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries. Br J Pharmacol 141:580-585 (Pubitemid 38453250)
11. Fullerton DA, Agrafojo J, McIntyre RC Jr (1996) Pulmonary vascular smooth muscle relaxation by cAMP-mediated pathways. J Surg Res 61:444-448 (Pubitemid 26087693)
12. Lai YJ, Pullamsetti SS, Dony E, Weissmann N, Butrous G, Banat GA, Ghofrani HA, Seeger W, Grimminger F, Schermuly RT (2008) Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension. Am J Respir Crit Care Med 178:188-196 (Pubitemid 351957777)
13. Qian YM, Jones RL, Chan KM, Stock AI, Ho JK (1994) Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery. Br J Pharmacol 113:369-374 (Pubitemid 24310729)
14. Jones RL, Qian YM, Chan KM, Yim AP (1998) Characterization of a prostanoid EP3-receptor in guinea-pig aorta: partial agonist action of the non-prostanoid ONO-AP-324. Br J Pharmacol 125:1288-1296 (Pubitemid 28542539)
15. Jadhav V, Jabre A, Lin SZ, Lee TJ (2004) EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries. J Cereb Blood Flow Metab 24:1305-1316 (Pubitemid 40019155)
16. Kobayashi K, Murata T, Hori M, Ozaki H (2011) Prostaglandin E2-prostanoid EP3 signal induces vascular contraction via nPKC and ROCK activation in rat mesenteric artery. Eur J Pharmacol 660:375-380
17. Shum WW, Le GY, Jones RL, Gurney AM, Sasaki Y (2003) Involvement of Rho-kinase in contraction of guinea-pig aorta induced by prostanoid EP3 receptor agonists. Br J Pharmacol 139:1449-1461 (Pubitemid 37174659)
18. Derici K, Samsar U, Demirel-Yilmaz E (2012) Nitric oxide effects depend on different mechanisms in different regions of the rat heart. Heart Vessels 27:89-97
19. Roan JN, Tsai YC, Chen IW, Chang SW, Huang CC, Lam CF (2012) Inhibition of cyclooxygenase-2 modulates phenotypic switching of vascular smooth muscle cells during increased aortic blood flow. Heart Vessels 27:307-315
20. Kringelholt S, Simonsen U, Bek T (2012) Dual effect of prostaglandins on isolated intraocular porcine ciliary arteries. Acta Ophthalmol. doi:10.1111/j.1755-3768.2012.02479.x
21. Ayabe S, Murata T, Maruyama T, Hori M, Ozaki H (2009) Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptors. Br J Pharmacol 156:835-845
22. Maruyama T, Murata T, Ayabe S, Hori M, Ozaki H (2008) Prostaglandin D(2) induces contraction via thromboxane A(2) receptor in rat liver myofibroblasts. Eur J Pharmacol 591:237-242
23. Janssen LJ, Tazzeo T (2002) Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature. J Pharmacol Exp Ther 301:1060-1066 (Pubitemid 34595098)
24. Jones RL, Qian Y, Wong HN, Chan H, Yim AP (1997) Prostanoid action on the human pulmonary vascular system. Clin Exp Pharmacol Physiol 24:969-972 (Pubitemid 27494310)
25. Ricciotti E, FitzGerald GA (2011) Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 31:986-1000
26. Devaux Y, Seguin C, Grosjean S, de Talance N, Camaeti V, Burlet A, Zannad F, Meistelman C, Mertes PM, Longrois D (2001) Lipopolysaccharide-induced increase of prostaglandin E(2) is mediated by inducible nitric oxide synthase activation of the constitutive cyclooxygenase and induction of membrane-associated prostaglandin E synthase. J Immunol 167:3962-3971 (Pubitemid 32910842)